---
title: "Weekly Recap | Bioventus +1.66%, most brokers rate it buy"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298096270.md"
description: "Bioventus (BVS) rose 1.66% to $14.07, outperforming the S&P 500, which added 0.09%, by about 1.57 percentage points. The stock opened weaker at $13.44 on Monday, recovered through midweek, and touched $14.50 on Thursday before easing back to $14.07 on Friday. Volume ran about 5% below the daily median in a week without a major catalyst."
datetime: "2026-09-05T06:23:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298096270.md)
  - [en](https://longbridge.com/en/news/298096270.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298096270.md)
generator: "portal-rs"
---

# Weekly Recap | Bioventus +1.66%, most brokers rate it buy

## The Week

Bioventus (BVS) rose 1.66% to $14.07, outperforming the S&P 500, which added 0.09%, by about 1.57 percentage points. The stock opened weaker at $13.44 on Monday, recovered through midweek, and touched $14.50 on Thursday before easing back to $14.07 on Friday. Volume ran about 5% below the daily median in a week without a major catalyst.

## Analyst Ratings

All five covering analysts rate BVS as either buy (3) or overweight (2), with no hold, underweight, or sell ratings. The consensus recommendation is strong buy, and the consensus target of $17.60 sits about 25.1% above the current price. Targets range from $15.00 to $19.00, and BVS ranks 19th out of 35 medical supplies companies.

## The Week Ahead

No company-specific reports or events are scheduled. Macro data due next week include the NFIB Small Business Optimism Index on 8 September, followed by initial jobless claims, final demand PPI, and existing home sales on 10 September. These releases could shape risk appetite for small- and mid-cap medical names like BVS.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [BVS.US](https://longbridge.com/en/quote/BVS.US.md)

## Related News & Research

- [Bioventus Inc. (NASDAQ:BVS) Given Consensus Recommendation of "Moderate Buy" by Analysts](https://longbridge.com/en/news/297881525.md)
- [Retractable Technologies, Inc. Supports Senator Blackburn’s ONSHORE Manufacturing Act | RVP Stock News](https://longbridge.com/en/news/297961114.md)
- [14:31 ETTelit Cinterion to Onshore its Trusted Manufacturing to the United States](https://longbridge.com/en/news/297818974.md)
- [HP Announces New OmniBook PCs to Help Build the Next Generation of AI Experiences | HPQ Stock News](https://longbridge.com/en/news/298065016.md)
- [Spectral AI executives present at H.C. Wainwright Global Investment Conference](https://longbridge.com/en/news/297653172.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**